未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏A first-in-human phase 1 study of SIM0270, a brain-penetrant oral selective estrogen receptor degrader (SERD), in patients with ER+/HER2-locally advanced or metastatic breast cancer
Wu, Jiong; Zhang, Jian; Zhang, Qingyuan; Sun, Yuping; Li, Hongtao; Yin, Yongmei; Shi, Yehui; Li, Wenfeng; Liu, Yunjiang; Yan, Min; Yang, Chen; Zhu, Lili; Yang, Yang; Xue, Liting
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer
Wu, Changjie; Qiu, Sunquan; Lu, Liting; Zou, Jiawei; Li, Wen-feng; Wang, Ouchen; Zhao, Haina; Wang, Hongxiao; Tang, Jiajia; Chen, Lin; Xu, Tao; Sun, Zhongsheng; Liao, Wanqin; Luo, Guangbin; Lu, Xincheng
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏